🇺🇸 PD-1 Antibody, chidamide, lenalidomide and etoposide in United States

PD-1 Antibody, chidamide, lenalidomide and etoposide (PD-1 Antibody, chidamide, lenalidomide and etoposide) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

PD-1 Antibody, chidamide, lenalidomide and etoposide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PD-1 Antibody, chidamide, lenalidomide and etoposide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for PD-1 Antibody, chidamide, lenalidomide and etoposide in United States?

Mingzhi Zhang is the originator. The local marketing authorisation holder may differ — check the official source linked above.